Within the Spain Peptide Anticoagulant Drugs Market, the anticoagulants segment dominates with a valuation of USD 88.82 million in 2024, capturing the largest share due to the critical need for preventing thromboembolic events. Other segments including antibiotics, ACE inhibitors, antifungals, and hormonal peptides are also gaining traction, with antibiotics witnessing notable growth amid...